Daniella Kranjac
InvestorGeneral Partner at Avant Bio Β· Founding Partner at Dynamk Capital Β· Board director at RoosterBio
New York, New York
Writes $3M β $10M checks Β· typically $5M
About
Senior figure at AVANT BIO, featured in 100 Women in Finance's profile series and nominated as an INNOVATE100 honoree.
ContactΒ· self-published, not guessed
Board director at RoosterBio
Intro paths
In turn, Daniella can intro founders to RoosterBio's investors below.
RoosterBio's investors Β· 6
Co-founders at RoosterBio

Experience
- Avant Bio LLCFounding GPcurrent2023 β presentNew York City Metropolitan Area
- Alpenglow BiosciencesBoard Membercurrent2023 β present
- CellFEBoard Membercurrent2022 β present
- Curi BioBoard Membercurrent2023 β present
- EnvisagenicsInvestor / Board Observer (2016-2022)current2017 β presentNew York City Metropolitan Area
- Intrepid LabsBoard Observercurrent2025 β presentToronto, Ontario, Canada
- RoosterBio Inc.Board Membercurrent2019 β present
- Virica BiotechBoard Membercurrent2021 β presentOttawa, Ontario, Canada
- Xcell BiosciencesBoard Observercurrent2021 β presentSan Francisco Bay Area
- Dynamk Consulting LLCFounder & CEOcurrent2015 β presentNew Jersey, USA
- Dynamk CapitalFounding Partnercurrent2017 β presentNew York City Metropolitan Area
- Global Women in VCMembercurrent2020 β present
- Vernal BiosciencesBoard Member2023 β 2025
- FloDesign SonicsBoard Member2017 β 2019
- GE HealthcareGlobal Head, Enterprise Solutions2014 β 2015Global virtual team: USA, Europe, Brazil, Australia, China, Singapore
- GE HealthcareHead of Business Development2013 β 2014Americas, Europe, Middle East
- GE HealthcareEnterprise Solutions Business Development2010 β 2013North America, Brazil & Latin America
- GE HealthcareIntegration Leader and Head, Commercial Operations2007 β 2010
- Wave Biotech LLCCo-Founder, Vice President1999 β 2007
Skills & more
+6 more
Technology TransferMarketing StrategyGMPProduct DevelopmentCross-functional Team LeadershipPharmaceutical IndustryLanguages Croatian
From Daniella's professional profile.
Deals Β· 4
ALPENGLOW BIOSCIENCES, INC.Board seat
via Avant Bio Β· filed Dec 2025 Β· $3M raise
RoosterBioBoard seat
via Avant Bio Β· filed Jul 2024 Β· $12M raise
Vernal BiosciencesBoard seat
via Avant Bio Β· filed Jun 2023 Β· $41M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Avant Bio
Network5
Investors connected to Daniella in public investor directories β a warm-intro map.
Frequently asked questions
- Who is Daniella Kranjac?
- Senior figure at AVANT BIO, featured in 100 Women in Finance's profile series and nominated as an INNOVATE100 honoree.
- Where does Daniella Kranjac work?
- Daniella Kranjac is General Partner at Avant Bio and Board director at RoosterBio.
- What check size does Daniella Kranjac write?
- Daniella Kranjac typically writes checks of $3M β $10M.
- What boards does Daniella Kranjac sit on?
- Daniella Kranjac holds tracked board seats at ALPENGLOW BIOSCIENCES, INC., RoosterBio, Vernal Biosciences, Virica.
- Where did Daniella Kranjac go to school?
- Daniella Kranjac studied at NYU Stern School of Business (Executive MBA); Harvard Business School (Executive Education, Private Equity and Venture Capital); Columbia Business School (Executive Education Program, Finance and Accounting for the non-Financial Executive).
Same school
Also attended NYU Stern School of Business430
+ 424 more
Also attended Harvard Business School2,000
+ 1,994 more
Also attended Columbia Business School668
+ 662 more
Also attended Stevens Institute of Technology24
+ 18 more













































